Addiction A-Z


Lotusate is the brand name for the generic talbutal, one of the barbiturates with a short to immediate duration of action. It is a Schedule III Controlled Substance in the United States. Lotusate is no longer available directly from the manufacturer and is likely only found on the street.

As a barbiturate, Lotusate acts as non-selective depressant of the central nervous system (CNS) and is capable of producing all levels of mood alteration from excitation to mild sedation, hypnosis and deep coma. Lotusate will also induce anesthesia when delivered in sufficiently high doses.

As a barbiturate, Lotusate could easily be known as a brain relaxer, much like alcohol. The effects of both on the brain are very similar. People will often use barbiturates such as Lotusate to try and achieve the same “high” they can generally achieve with alcohol intoxication. In attempting this high with Lotusate, the person is at increased risk as the window between the dose causing drowsiness and the one causing death can be very small.

Whenever Lotusate is taken for longer than just a couple of weeks or when taken recreationally for non-medical purposes, addiction can easily emerge. Such users tend to take more than the safe amount to achieve a desired “high”, resulting in abuse of the drug. Over time, the brain develops a need for Lotusate, making it very difficult for the user to function without it.

Lotusate depresses the respiratory and nervous system functions, therefore it increases the risk of building a tolerance to the drug very rapidly. For a person who is dependent or addicted to Lotusate, withdrawal symptoms can occur 12-20 hours after the last dose and remain for several weeks or even months.

Withdrawal symptoms associated with cessation of Lotusate can include, but are not limited to:

  • Anxiety
  • Muscle pain
  • Elevated heart rate
  • Elevated respiration rate
  • Nausea
  • Confusion
  • Hallucinations
  • Seizures

The treatment of a Lotusate addiction can vary depending upon the level of addiction. The first step is for a patient to be evaluated by a board-certified physician and psychiatrist to determine the proper method for treatment.

Comments are closed.
  • 877-825-8131